FINANCE87 Videos

Order By: Comments

The Latest “Buzz on the Street” Video Recap: Featuring (NYSE: MCD) & (NYSE: CAT) 2018 Q3 Earning

FinancialBuzz.com’s latest offering, Buzz on the Street, presents “Recap of McDonald’s & Caterpillar 2018 Q3 Earning.” About Buzz on the Street: One of FinancialBuzz.com’s latest corporate and financial news shows, covering the latest trending stock market news. Buzz on the Street looks to become a leader in corporate video news dissemination. Buzz on the Street […]

“Buzz on the Street” Show: Featuring Koios Beverage Corp.(OTC: KBEVF) (CSE: KBEV) News

Former Key Account Manager for Constellation Brands Joins Koios Beverage Advisory Board” The Latest “Buzz on the Street” Show: Featuring Koios Beverage Corp. News Koios Beverage Corp. (OTC: KBEVF) (CSE: KBEV) a market leader in the functional beverage space, is pleased to announce the appointment of Aussie Jiwani to the Company’s Advisory Board. Mr. Jiwani […]

“Behind the Buzz” Show: Field Trip Ventures Inc. Co-Founder Ronan Levy

Field Trip Ventures Inc.’s mission is to heal the sick, and better the well, through therapeutic psychedelics. Field Trip is a first-of-its-kind venture that is blending operational execution with strategic investing across all aspects of the psychedelics value chain — from basic research on botanical psychedelics to operation of world class clinics focused on psychedelics-assisted […]

“Buzz on the Street” Show: Stock Market Report (NYSE: CRM RH WORK) (NASDAQ: EXPE)

Salesforce.com, Inc. (NYSE: CRM) released its third quarter results on Tuesday evening, surpassing revenue and earnings, yet still trended downwards as its largest ever acquisition handed the company a net loss for the quarter, and an EPS of 75 cents and revenues of 4.5 billion dollars were not enough to appease investors. Then the Expedia […]

“Buzz on the Street” Show: Amarantus Bioscience (OTC: AMBS) Eltoprazine & CBD to Treat Parkinson’s

Amarantus Bioscience Holdings, Inc. (OTC: AMBS) (“Amarantus,” or AMBS), a US-based JLABS-alumnus biotechnology holding company developing proprietary orphan neurologic, regenerative medicine and ophthalmic therapies and diagnostics through its subsidiaries, today announced that subsidiary Elto Pharma, Inc. has received a notice of allowance from the European Patent Office (EPO) covering the use of eltoprazine and eltoprazine […]

“Buzz on the Street” Show: Dec. 2, 2019 Earnings Focus (NYSE: CRM WORK CLDR) (NASDAQ: CRWD)

Salesforce.com, Inc. (NYSE: CRM) will release its 3rd quarter 2020 results on Tuesday after market close with analysts expecting an EPS of $0.66 cents on revenues of 4.4 billion dollars. Then Slack Technologies, Inc. (NYSE: WORK) report will follow on Wednesday evening with expected earnings losses of 8 cents on revenues of just over 156 […]

“Buzz on the Street” Show: Q BioMed (OTCQB: QBIO) Mannin Research Reports Data: Acute Kidney Injury

Q BioMed Inc. (OTCQB: QBIO), a commercial stage biotech company, is announcing today that its technology research partner Mannin Research Inc. (Mannin) presented positive data on a potential new treatment for acute kidney injury (AKI). The data was presented at the American Society for Nephrology 2019 Annual Meeting held in Washington DC. Q BioMed Inc. […]

“Buzz on the Street” Show: Nov. 25, 2019 Earnings Focus for the Week (NYSE: PANW BBY) (NASDAQ: NTNX)

Palo Alto Networks, Inc. (NYSE: PANW) will report its fiscal year 2020 first quarter results after the market closes Monday, with analysts expecting an EPS of $1.03 cents on sales of $768 million dollars Concurrently, Nutanix, Inc. (NASDAQ: NTNX) will also release its first quarter results as analysts expect a loss per share of 75 […]

“Buzz on the Street” Show: Stock Market Retail Report (NYSE: KSS TGT LB) (NASDAQ: URBN)

Kohl’s Corporation (NYSE: KSS) shares tanked by more than 16% on Tuesday after the Company reduced its outlook and missed analyst expectations with earnings of 0.74 cents on revenues of $4.36 billion Then, Urban Outfitters, Inc. (NASDAQ: URBN) slumped more than 14% on Wednesday after it reported earnings of 56 cents per share and revenues […]

“Buzz on the Street” Show: Amarantus Bioscience (OTC: AMBS) Patent to Treat Retinal Disorders

Amarantus Bioscience Holdings, Inc. (OTC: AMBS), a US-based JLABS-alumnus biotechnology holding company developing proprietary orphan neurologic, regenerative medicine and ophthalmic therapies and diagnostics through its subsidiaries, today announced that subsidiary MANF Therapeutics has been issued a Chinese patent covering the use of mesencephalic astrocyte-derived neurotrophic factor (MANF) and/or cerebral dopamine neurotrophic factor (CDNF) for the […]